CatalystCorporate
Animal Model - Global Strategic Business Report: Market Size to Surge to $3.6 Billion by 2032 as CRISPR Disrupts R&D - Benchmark Charles River, Biocytogen, Crown Bioscience, Cyagen and The Jackso
Market size projected to reach $3.6 billion by 2032, driven by CRISPR disrupting R&D.
What changed
Market size projected to reach $3.6 billion by 2032, driven by CRISPR disrupting R&D.
Why it matters
Market size projected to reach $3.6 billion by 2032, driven by CRISPR disrupting R&D. — impact context not separately stored; see What changed.